Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes

A Aydh; RS Motlagh; A Alamri; T Yanagisawa; A Ayed; P Rajwa; E Laukhtina; SM Alasiri; T Kawada; H Mostafai; A Ayidh; Maximilian Pallauf; F Konig; M Abufaraj; PI Karakiewicz; SF Shariat

doi:10.1007/s00345-023-04478-w

Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes

A Aydh
, RS Motlagh
, A Alamri
, T Yanagisawa
, A Ayed
, P Rajwa
, E Laukhtina
, SM Alasiri
, T Kawada
, H Mostafai
, A Ayidh
, Maximilian Pallauf (Co-author)
, F Konig
, M Abufaraj
, PI Karakiewicz
, SF Shariat

Department of Urology and Andrology

Research output: Contribution to journal › Review article › peer-review

9 Citations (Web of Science)

Original language	English
Pages (from-to)	2185-2194
Journal	WORLD JOURNAL OF UROLOGY
Volume	41
Issue number	8
DOIs	https://doi.org/10.1007/s00345-023-04478-w
Publication status	Published - 2023

Keywords

TRANSITIONAL-CELL-CARCINOMA
PHASE-III TRIAL
RADICAL CYSTECTOMY
CISPLATIN
METHOTREXATE
VINBLASTINE
GEMCITABINE
SURVIVAL
DOXORUBICIN

Access to Document

10.1007/s00345-023-04478-w

Cite this

Aydh, A., Motlagh, RS., Alamri, A., Yanagisawa, T., Ayed, A., Rajwa, P., Laukhtina, E., Alasiri, SM., Kawada, T., Mostafai, H., Ayidh, A., Pallauf, M., Konig, F., Abufaraj, M., Karakiewicz, PI., & Shariat, SF. (2023). Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes. WORLD JOURNAL OF UROLOGY , 41(8), 2185-2194. https://doi.org/10.1007/s00345-023-04478-w

Aydh, A ; Motlagh, RS ; Alamri, A et al. / Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes. In: WORLD JOURNAL OF UROLOGY 2023 ; Vol. 41, No. 8. pp. 2185-2194.

@article{e554d701570949b592364bcb25d24256,

title = "Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes",

keywords = "TRANSITIONAL-CELL-CARCINOMA, PHASE-III TRIAL, RADICAL CYSTECTOMY, CISPLATIN, METHOTREXATE, VINBLASTINE, GEMCITABINE, SURVIVAL, DOXORUBICIN",

author = "A Aydh and RS Motlagh and A Alamri and T Yanagisawa and A Ayed and P Rajwa and E Laukhtina and SM Alasiri and T Kawada and H Mostafai and A Ayidh and Maximilian Pallauf and F Konig and M Abufaraj and PI Karakiewicz and SF Shariat",

note = "Pallauf: Department of Urology, University Hospital Salzburg, Paracelsus Medical University Salzburg, Salzburg, Austria",

year = "2023",

doi = "10.1007/s00345-023-04478-w",

language = "English",

volume = "41",

pages = "2185--2194",

journal = "WORLD JOURNAL OF UROLOGY ",

issn = "0724-4983",

publisher = "Springer Nature",

number = "8",

}

Aydh, A, Motlagh, RS, Alamri, A, Yanagisawa, T, Ayed, A, Rajwa, P, Laukhtina, E, Alasiri, SM, Kawada, T, Mostafai, H, Ayidh, A, Pallauf, M, Konig, F, Abufaraj, M, Karakiewicz, PI & Shariat, SF 2023, 'Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes', WORLD JOURNAL OF UROLOGY , vol. 41, no. 8, pp. 2185-2194. https://doi.org/10.1007/s00345-023-04478-w

Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes. / Aydh, A; Motlagh, RS; Alamri, A et al.
In: WORLD JOURNAL OF UROLOGY , Vol. 41, No. 8, 2023, p. 2185-2194.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes

AU - Aydh, A

AU - Motlagh, RS

AU - Alamri, A

AU - Yanagisawa, T

AU - Ayed, A

AU - Rajwa, P

AU - Laukhtina, E

AU - Alasiri, SM

AU - Kawada, T

AU - Mostafai, H

AU - Ayidh, A

AU - Pallauf, Maximilian

AU - Konig, F

AU - Abufaraj, M

AU - Karakiewicz, PI

AU - Shariat, SF

N1 - Pallauf: Department of Urology, University Hospital Salzburg, Paracelsus Medical University Salzburg, Salzburg, Austria

PY - 2023

Y1 - 2023

KW - TRANSITIONAL-CELL-CARCINOMA

KW - PHASE-III TRIAL

KW - RADICAL CYSTECTOMY

KW - CISPLATIN

KW - METHOTREXATE

KW - VINBLASTINE

KW - GEMCITABINE

KW - SURVIVAL

KW - DOXORUBICIN

U2 - 10.1007/s00345-023-04478-w

DO - 10.1007/s00345-023-04478-w

M3 - Review article

C2 - 37347252

SN - 0724-4983

VL - 41

SP - 2185

EP - 2194

JO - WORLD JOURNAL OF UROLOGY

JF - WORLD JOURNAL OF UROLOGY

IS - 8

ER -

Aydh A, Motlagh RS, Alamri A, Yanagisawa T, Ayed A, Rajwa P et al. Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes. WORLD JOURNAL OF UROLOGY . 2023;41(8):2185-2194. doi: 10.1007/s00345-023-04478-w